Works by Cork, Michael J.
Results: 81
Practical Management of the JAK1 Inhibitor Abrocitinib for Atopic Dermatitis in Clinical Practice: Special Safety Considerations.
- Published in:
- Dermatology & Therapy, 2024, v. 14, n. 8, p. 2285, doi. 10.1007/s13555-024-01200-5
- By:
- Publication type:
- Article
Maintenance of an Acidic Skin Surface with a Novel Zinc Lactobionate Emollient Preparation Improves Skin Barrier Function in Patients with Atopic Dermatitis.
- Published in:
- Dermatology & Therapy, 2024, v. 14, n. 2, p. 391, doi. 10.1007/s13555-023-01084-x
- By:
- Publication type:
- Article
Dupilumab Safety and Efficacy in a Phase III Open-Label Extension Trial in Children 6–11 Years of Age with Severe Atopic Dermatitis.
- Published in:
- Dermatology & Therapy, 2023, v. 13, n. 11, p. 2697, doi. 10.1007/s13555-023-01016-9
- By:
- Publication type:
- Article
Dupilumab Treatment Leads to Rapid and Consistent Improvement of Atopic Dermatitis in All Anatomical Regions in Patients Aged 6 Months to 5 Years.
- Published in:
- Dermatology & Therapy, 2023, v. 13, n. 9, p. 1987, doi. 10.1007/s13555-023-00960-w
- By:
- Publication type:
- Article
Response to: Letter to the Editor Regarding "An Investigation of the Skin Barrier Restoring Effects of a Cream and Lotion Containing Ceramides in a Multi-Vesicular Emulsion in People with Dry, Eczema-Prone, Skin: The RESTORE Study Phase 1".
- Published in:
- Dermatology & Therapy, 2021, v. 11, n. 6, p. 2249, doi. 10.1007/s13555-021-00623-8
- By:
- Publication type:
- Article
Dupilumab Demonstrates Rapid and Consistent Improvement in Extent and Signs of Atopic Dermatitis Across All Anatomical Regions in Pediatric Patients 6 Years of Age and Older.
- Published in:
- Dermatology & Therapy, 2021, v. 11, n. 5, p. 1643, doi. 10.1007/s13555-021-00568-y
- By:
- Publication type:
- Article
An Investigation of the Skin Barrier Restoring Effects of a Cream and Lotion Containing Ceramides in a Multi-vesicular Emulsion in People with Dry, Eczema-Prone, Skin: The RESTORE Study Phase 1.
- Published in:
- Dermatology & Therapy, 2020, v. 10, n. 5, p. 1031, doi. 10.1007/s13555-020-00426-3
- By:
- Publication type:
- Article
Comparison of the Simple Patient-Centric Atopic Dermatitis Scoring System PEST with SCORAD in Young Children Using a Ceramide Dominant Therapeutic Moisturizer.
- Published in:
- Dermatology & Therapy, 2017, v. 7, n. 3, p. 383, doi. 10.1007/s13555-017-0186-1
- By:
- Publication type:
- Article
Patch testing is a useful investigation in children with eczema.
- Published in:
- Contact Dermatitis (01051873), 2011, v. 65, n. 4, p. 208, doi. 10.1111/j.1600-0536.2011.01900.x
- By:
- Publication type:
- Article
Occupational vitiligo and contact sensitivity to para-tertiary butyl catechol.
- Published in:
- Contact Dermatitis (01051873), 1991, v. 25, n. 3, p. 200, doi. 10.1111/j.1600-0536.1991.tb01838.x
- By:
- Publication type:
- Article
An Update on the Safety and Tolerability of Pimecrolimus Cream 1%: Evidence from Clinical Trials and Post-Marketing Surveillance.
- Published in:
- Dermatology (10188665), 2007, v. 215, p. 27, doi. 10.1159/000102118
- By:
- Publication type:
- Article
Structure and polymorphism of the human gene for the interferon-induced p78 protein (MX1): evidence of association with alopecia areata in the Down syndrome region.
- Published in:
- Human Genetics, 2000, v. 106, n. 6, p. 639, doi. 10.1007/s004390000318
- By:
- Publication type:
- Article
The effect of water hardness on atopic eczema, skin barrier function: A systematic review, meta‐analysis.
- Published in:
- Clinical & Experimental Allergy, 2021, v. 51, n. 3, p. 430, doi. 10.1111/cea.13797
- By:
- Publication type:
- Article
Characterization of skin barrier defects using infrared spectroscopy in patients with atopic dermatitis.
- Published in:
- Clinical & Experimental Dermatology, 2024, v. 49, n. 5, p. 466, doi. 10.1093/ced/llad416
- By:
- Publication type:
- Article
Early improvements in signs and symptoms predict clinical response to baricitinib in patients with moderate-to-severe atopic dermatitis.
- Published in:
- Clinical & Experimental Dermatology, 2023, v. 48, n. 8, p. 881, doi. 10.1093/ced/llad129
- By:
- Publication type:
- Article
Different types of emollient cream exhibit diverse physiological effects on the skin barrier in adults with atopic dermatitis.
- Published in:
- Clinical & Experimental Dermatology, 2022, v. 47, n. 6, p. 1154, doi. 10.1111/ced.15141
- By:
- Publication type:
- Article
The role of Staphylococcus aureus in atopic eczema: treatment strategies.
- Published in:
- Journal of the European Academy of Dermatology & Venereology, 1996, v. 7, p. S31, doi. 10.1111/j.1468-3083.1996.tb00007.x
- By:
- Publication type:
- Article
Association analysis of IL1A andIL1B variants in alopecia areata.
- Published in:
- Heredity, 2001, v. 87, n. 2, p. 215, doi. 10.1046/j.1365-2540.2001.00916.x
- By:
- Publication type:
- Article
HLA-C, CSTA and DS12346 susceptibility alleles confer over 100-fold increased risk of developing psoriasis: evidence of gene interaction.
- Published in:
- Journal of Human Genetics, 2011, v. 56, n. 6, p. 423, doi. 10.1038/jhg.2011.33
- By:
- Publication type:
- Article
Single nucleotide polymorphisms in the human interleukin-1B gene affect transcription according to haplotype context.
- Published in:
- Human Molecular Genetics, 2006, v. 15, n. 4, p. 519, doi. 10.1093/hmg/ddi469
- By:
- Publication type:
- Article
Clinically Meaningful Responses to Dupilumab Among Children Aged 6 Months to 5 Years with Moderate-to-severe Atopic Dermatitis who did Not Achieve Clear or Almost Clear Skin According to the Investigator's Global Assessment: A Post Hoc Analysis of a Phase 3 Trial.
- Published in:
- Acta Dermato-Venereologica, 2024, v. 104, p. 1, doi. 10.2340/actadv.v104.13467
- By:
- Publication type:
- Article
Olive Oil, Sunflower Oil or no Oil for Baby Dry Skin or Massage: A Pilot, Assessor-blinded, Randomized Controlled Trial (the Oil in Baby SkincaRE [OBSeRvE] Study).
- Published in:
- Acta Dermato-Venereologica, 2016, v. 96, n. 3, p. 323, doi. 10.2340/00015555-2279
- By:
- Publication type:
- Article
Comparing the Effect of a Twice-weekly Tacrolimus and Betamethasone Valerate Dose on the Subclinical Epidermal Barrier Defect in Atopic Dermatitis.
- Published in:
- Acta Dermato-Venereologica, 2015, v. 95, n. 6, p. 653, doi. 10.2340/00015555-2048
- By:
- Publication type:
- Article
Efficacy and safety of crisaborole in patients with mild-tomoderate atopic dermatitis and other atopic comorbidities.
- Published in:
- Allergy & Asthma Proceedings, 2021, v. 42, n. 5, p. 425, doi. 10.2500/aap.2021.42.210064
- By:
- Publication type:
- Article
Infections in Children Aged 6 Months to 5 Years Treated with Dupilumab in a Placebo-Controlled Clinical Trial of Moderate-to-Severe Atopic Dermatitis.
- Published in:
- Pediatric Drugs, 2024, v. 26, n. 2, p. 163, doi. 10.1007/s40272-023-00611-9
- By:
- Publication type:
- Article
Laboratory Safety from a Randomized 16-Week Phase III Study of Dupilumab in Children Aged 6 Months to 5 Years with Moderate-to-Severe Atopic Dermatitis.
- Published in:
- Pediatric Drugs, 2023, v. 25, n. 1, p. 67, doi. 10.1007/s40272-022-00553-8
- By:
- Publication type:
- Article
Laboratory Safety of Dupilumab in Patients Aged 6–11 Years with Severe Atopic Dermatitis: Results from a Phase III Clinical Trial.
- Published in:
- Pediatric Drugs, 2021, v. 23, n. 5, p. 515, doi. 10.1007/s40272-021-00459-x
- By:
- Publication type:
- Article
Pharmacokinetics and pharmacodynamics of itepekimab in adults with moderate‐to‐severe atopic dermatitis: Results from two terminated phase II trials.
- Published in:
- CTS: Clinical & Translational Science, 2024, v. 17, n. 8, p. 1, doi. 10.1111/cts.13874
- By:
- Publication type:
- Article
Epidermal Barrier Dysfunction in Atopic Dermatitis.
- Published in:
- Journal of Investigative Dermatology, 2009, v. 129, n. 8, p. 1892, doi. 10.1038/jid.2009.133
- By:
- Publication type:
- Article
Single-Point Haplotype Scores Telomeric to Human Leukocyte Antigen-C Give a High Susceptibility Major Histocompatability Complex Haplotype for Psoriasis in a Caucasian Population.
- Published in:
- Journal of Investigative Dermatology, 2005, v. 124, n. 3, p. 545, doi. 10.1111/j.0022-202X.2005.23604.x
- By:
- Publication type:
- Article
Improved emollient use reduces atopic eczema symptoms and is cost neutral in infants: before-and-after evaluation of a multifaceted educational support programme.
- Published in:
- BMC Dermatology, 2013, v. 13, n. 1, p. 1, doi. 10.1186/1471-5945-13-7
- By:
- Publication type:
- Article
Improved emollient use reduces atopic eczema symptoms and is cost neutral in infants: before-and-after evaluation of a multifaceted educational support programme.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Effects of a pH-Regulating Emollient Cream in Mild Atopic Dermatitis Patients with Moderate Localized Lesions.
- Published in:
- Skin Pharmacology & Physiology, 2024, v. 37, n. 1-3, p. 49, doi. 10.1159/000541022
- By:
- Publication type:
- Article
The Effect of an Emollient Containing Urea, Ceramide NP, and Lactate on Skin Barrier Structure and Function in Older People with Dry Skin.
- Published in:
- Skin Pharmacology & Physiology, 2016, v. 29, n. 3, p. 135, doi. 10.1159/000445955
- By:
- Publication type:
- Article
Efficacy and Safety of Dupilumab in Patients With Erythrodermic Atopic Dermatitis: A Post Hoc Analysis of 6 Randomized Clinical Trials.
- Published in:
- JAMA Dermatology, 2023, v. 159, n. 3, p. 255, doi. 10.1001/jamadermatol.2022.6192
- By:
- Publication type:
- Article
Dupilumab Treatment in Pediatric Patients Aged 6–11 Years with Severe Atopic Dermatitis Whose Disease Is Not Adequately Controlled: A Review.
- Published in:
- Drug Design, Development & Therapy, 2024, v. 18, p. 277, doi. 10.2147/DDDT.S426947
- By:
- Publication type:
- Article
Association analysis of the skin barrier gene cystatin A at the PSORS5 locus in psoriatic patients: evidence for interaction between PSORS1 and PSORS5.
- Published in:
- European Journal of Human Genetics, 2008, v. 16, n. 8, p. 1002, doi. 10.1038/ejhg.2008.40
- By:
- Publication type:
- Article
Vitamin D Receptor Polymorphism and Calcipotriol Response in Patients with Psoriasis.
- Published in:
- Journal of Investigative Dermatology, 1998, v. 110, n. 3, p. 301, doi. 10.1046/j.1523-1747.1998.00128.x
- By:
- Publication type:
- Article
Comparative Genetic Association of Human Leukocyte Antigen Class II and Tumor Necrosis Factor-Alpha with Dermatitis Herpetiformis.
- Published in:
- Journal of Investigative Dermatology, 1995, v. 104, n. 5, p. 856, doi. 10.1111/1523-1747.ep12607031
- By:
- Publication type:
- Article
Severity of Alopecia Areata Is Associated with a Polymorphism in the Interleukin-1 Receptor Antagonist Gene.
- Published in:
- Journal of Investigative Dermatology, 1994, v. 103, n. 3, p. 387, doi. 10.1111/1523-1747.ep12395398
- By:
- Publication type:
- Article
Skin barrier breakdown: a renaissance in emollient therapy.
- Published in:
- British Journal of Community Nursing, 2009, v. 14, p. 4
- By:
- Publication type:
- Article
701 - Dupilumab efficacy and safety up to 2 years in children aged 6 months to 5 years with atopic dermatitis.
- Published in:
- British Journal of Dermatology, 2024, v. 191, p. 1, doi. 10.1093/bjd/ljae266.075
- By:
- Publication type:
- Article
Dupilumab improves patient-reported symptoms and health-related quality of life in children aged 6–11 years with severe atopic dermatitis.
- Published in:
- British Journal of Dermatology, 2023, v. 189, n. 2, p. 238, doi. 10.1093/bjd/ljad124
- By:
- Publication type:
- Article
410 Dupilumab treatment reduces total IgE levels in patients 6 months and older with moderate-to-severe atopic dermatitis.
- Published in:
- British Journal of Dermatology, 2023, v. 188, p. 1, doi. 10.1093/bjd/ljad162.031
- By:
- Publication type:
- Article
411 Long term laboratory safety of dupilumab in patients aged 6 months to 5 years with moderate-to-severe atopic dermatitis.
- Published in:
- British Journal of Dermatology, 2023, v. 188, p. 1, doi. 10.1093/bjd/ljad162.032
- By:
- Publication type:
- Article
383 Integrated safety analysis of abrocitinib in 635 adolescent patients with moderate-to-severe atopic dermatitis with over 1000 patient-years of exposure.
- Published in:
- British Journal of Dermatology, 2023, v. 188, p. 1, doi. 10.1093/bjd/ljad162.011
- By:
- Publication type:
- Article
337 Dupilumab treatment is not associated with an increased overall risk of infections in patients aged 6 months to 5 years with moderate-to-severe atopic dermatitis.
- Published in:
- British Journal of Dermatology, 2023, v. 188, p. ii25, doi. 10.1093/bjd/ljac140.031
- By:
- Publication type:
- Article
Enhancement of stratum corneum lipid structure improves skin barrier function and protects against irritation in adults with dry, eczema‐prone skin*.
- Published in:
- British Journal of Dermatology, 2022, v. 186, n. 5, p. 875, doi. 10.1111/bjd.20955
- By:
- Publication type:
- Article
Novel genetic association between the corneodesmosin (MHC S) gene and susceptibility to psoriasis.
- Published in:
- Human Molecular Genetics, 1999, v. 8, n. 6, p. 1135, doi. 10.1093/hmg/8.6.1135
- By:
- Publication type:
- Article
Dupilumab Safety and Efficacy up to 1 Year in Children Aged 6 Months to 5 Years with Atopic Dermatitis: Results from a Phase 3 Open-Label Extension Study.
- Published in:
- American Journal of Clinical Dermatology, 2024, v. 25, n. 4, p. 655, doi. 10.1007/s40257-024-00859-y
- By:
- Publication type:
- Article